Get the Stockscreener App
3.10
14.81%
0.40
Okyo Pharma Limited stock is traded at $3.10, with a volume of 799.33K.
It is up +14.81% in the last 24 hours and up +18.77% over the past month.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
See More
Previous Close:
$2.70
Open:
$2.9
24h Volume:
799.33K
Relative Volume:
4.23
Market Cap:
$116.59M
Revenue:
-
Net Income/Loss:
$-13.27M
P/E Ratio:
-18.90
EPS:
-0.164
Net Cash Flow:
$-7.70M
1W Performance:
+12.73%
1M Performance:
+18.77%
6M Performance:
+192.45%
1Y Performance:
+211.56%
1-Day Range:
$2.75
$3.15
1-Week Range:
$2.46
$3.15
52-Week Range:
$0.8075
$3.15
Okyo Pharma Limited Stock (OKYO) Company Profile
Compare OKYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
3.10 | 101.55M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Okyo Pharma Limited Stock (OKYO) Latest News
Visual analytics tools that track OKYO Pharma Limited performanceBuy Strategy with Smart Exit Timing - Newser
What high frequency data says about OKYO Pharma LimitedFundamental Analysis for Value Stock Selection - Newser
How to use a screener to detect OKYO Pharma Limited breakoutsReversal Pattern Insights with Entry Tips - Newser
Will OKYO Pharma Limited bounce back from current supportFree Weekly Growth Stock Entry Point Alerts - Newser
Why OKYO Pharma Limited stock attracts strong analyst attentionFree Day Trading Signals With High Precision - Newser
Can OKYO Pharma Limited rally from current levelsTechnical Trend Forecast for Investors - Newser
How strong is OKYO Pharma Limited company’s balance sheetExpert Picks Insights For Consistent Profits - jammulinksnews.com
Top chart patterns to watch in OKYO Pharma LimitedWeekly Stock Picks with Trend Confidence - Newser
Why is OKYO Pharma Limited stock attracting strong analyst attentionBeginner Investor Growth Plan For Every Investor - jammulinksnews.com
How many analysts rate OKYO Pharma Limited as a “Buy”Pre Market Target Finder For 2025 - jammulinksnews.com
Promising Developments in OKYO Pharma’s Urcosimod Program Drive Buy Rating and $7 Price Target - TipRanks
AI Tools Suggest OKYO Pharma Limited May Outperform This WeekInvestment Plan With Growth Optimization Finalized - metal.it
Should I hold or sell OKYO Pharma Limited stock in 2025Capitalize on market shifts before others do - jammulinksnews.com
How does OKYO Pharma Limited compare to its industry peersMaximize your returns with expert insights - jammulinksnews.com
Analyzing OKYO Pharma Limited with risk reward ratio chartsFree Growth Based Stock Signal Screener - Newser
What are OKYO Pharma Limited company’s key revenue driversUnlock powerful trading signals and alerts - jammulinksnews.com
What is OKYO Pharma Limited company’s growth strategyAchieve consistent double-digit returns - jammulinksnews.com
What markets is OKYO Pharma Limited expanding into Is BAYA stock a good long term investment option - jammulinksnews.com
Is it the right time to buy OKYO Pharma Limited stockSky-high profits - jammulinksnews.com
What are the latest earnings results for OKYO Pharma LimitedTransform your portfolio with high-yield stocks - jammulinksnews.com
What catalysts could drive OKYO Pharma Limited stock higher in 2025Free Stock Selection - jammulinksnews.com
What is the risk reward ratio of investing in OKYO Pharma Limited stockInvest smarter with real-time trading alerts - jammulinksnews.com
Published on: 2025-07-27 19:17:36 - jammulinksnews.com
How Resilient Is OKYO Pharma Limited Stock During Economic DownturnsFast Moving Stock Alerts - Newser
How OKYO Pharma Limited stock performs during market volatilityControlled Risk High Reward Plan - Newser
OKYO Pharma Limited Stock Analysis and ForecastMarket-beating returns - PrintWeekIndia
What analysts say about OKYO Pharma Limited stockMassive stock growth - PrintWeekIndia
What institutions are buying OKYO Pharma Limited stock nowFree Market Dynamics Reports - jammulinksnews.com
Will OKYO Pharma Limited stock benefit from AI tech trendsExplosive market performance - jammulinksnews.com
OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile
What drives OKYO Pharma Limited stock priceAccelerated wealth expansion - Autocar Professional
Is OKYO Pharma Limited a good long term investmentPhenomenal trading returns - Autocar Professional
Okyo Pharma Limited Stock (OKYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):